Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengxuebao Heji is a Traditional Chinese Medicine (TCM) herbal mixture developed and manufactured by Xi'an Happiness Pharmaceutical. It is formulated to tonify the liver and kidney while nourishing qi and blood, addressing systemic deficiencies often seen in chronic illness or following aggressive medical treatments. The mixture is clinically indicated for the treatment of iron deficiency anemia and leukopenia, particularly as supportive therapy for patients experiencing bone marrow suppression (leukopenia and pancytopenia) resulting from chemotherapy or radiotherapy. Its composition includes several key botanical ingredients such as processed *Polygonum multiflorum*, *Ligustrum lucidum*, *Eclipta prostrata*, *Morus alba*, and *Astragalus membranaceus*, which are traditionally used to stimulate hematopoiesis and enhance immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shengxuebao Heji.